Primary experimental recordPositive observation

PMC13138602::ACT044660

Phoenixin-14 amide

Evidence text

Paper-level observation

Treatment with PNX-14 at 2.5 nmol increased this count to 9.8 ± 1.0% (P < 0.05 vs PCOS), with no significant changes observed at higher doses (Fig. 3D).

textConfidence: medium

Assay observation

Activity

Metabolic/Cardiovascular

Subtype

Other

Measure

other

Comparator

Raw observation

9.8 ± 1.0%

Normalized measurement

=9.8%

Value minimum

Not reported by source

Value maximum

Not reported by source

Target

Rattus norvegicus

Assay method

Not reported by source

Sequence

DVQPPGLKVWSDPFNH

Standardization

ready simple

Source publication

Phoenixin-14 ameliorates ovarian morphology in a DHEA-induced rat model of PCOS

Reproduction & Fertility · 2026

DOI 10.1530/RAF-25-0142 PMC13138602

Parent mention

Related peptide identities

PEPDIA-PLP-000501

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.